lncSNHG16 promotes hepatocellular carcinoma development by inhibiting autophagy.
- Published in:
- Clinical & Translational Oncology, 2025, v. 27, n. 4, p. 1612, doi. 10.1007/s12094-024-03730-y
- By:
- Publication type:
- Article
Works by Deng, Zhu-Jian
Results: 11
1
2
miR-17-5p slows progression of hepatocellular carcinoma by downregulating TGFβR2.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 10, p. 2960, doi. 10.1007/s12094-023-03164-y
- By:
- Publication type:
- Article
3
Lenvatinib with or without immune checkpoint inhibitors for patients with unresectable hepatocellular carcinoma in real-world clinical practice.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 5, p. 1063, doi. 10.1007/s00262-021-03060-w
- By:
- Publication type:
- Article
4
Prognosis after hepatic resection of patients with hepatocellular carcinoma related to non-alcoholic fatty liver disease: meta-analysis.
- Published in:
- BJS Open, 2023, v. 7, n. 1, p. 1, doi. 10.1093/bjsopen/zrac167
- By:
- Publication type:
- Article
5
Second-line treatment options for hepatocellular carcinoma: current state and challenges for the future.
- Published in:
- Expert Opinion on Investigational Drugs, 2022, v. 31, n. 11, p. 1151, doi. 10.1080/13543784.2022.2151891
- By:
- Publication type:
- Article
6
Prevalence of metabolic syndrome among patients with hepatocellular carcinoma of different etiologies: a retrospective study.
- Published in:
- Infectious Agents & Cancer, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13027-024-00575-6
- By:
- Publication type:
- Article
7
Prevalence of metabolic syndrome among patients with hepatocellular carcinoma of different etiologies: a retrospective study.
- Published in:
- Infectious Agents & Cancer, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13027-024-00575-6
- By:
- Publication type:
- Article
8
Dose–Response Between Serum Prealbumin and All-Cause Mortality After Hepatectomy in Patients With Hepatocellular Carcinoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.596691
- By:
- Publication type:
- Article
9
Letter: sex disparity in prognosis of patients with hepatocellular carcinoma after resection.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 11/12, p. 1767, doi. 10.1111/apt.16089
- By:
- Publication type:
- Article
10
Outcomes of Liver Resection for Metabolic Dysfunction-Associated Fatty Liver Disease or Chronic Hepatitis B-Related HCC.
- Published in:
- Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.783339
- By:
- Publication type:
- Article
11
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Progresses and Challenges.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.737497
- By:
- Publication type:
- Article